Site 5112, David Geffen School of Medicine at UCLA NICHD CRS — Los Angeles, California

Site 5112, David Geffen School of Medicine at UCLA NICHD CRS is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 5112, David Geffen School of Medicine at UCLA NICHD CRS has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pregnancy.

Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 5112, David Geffen School of Medicine at UCLA NICHD CRS?

Site 5112, David Geffen School of Medicine at UCLA NICHD CRS has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 5112, David Geffen School of Medicine at UCLA NICHD CRS conducted?

Site 5112, David Geffen School of Medicine at UCLA NICHD CRS has 1 clinical trials on record, with 1 currently active. Their work covers Pregnancy.

Is Site 5112, David Geffen School of Medicine at UCLA NICHD CRS accredited by Crixeo Health?

Site 5112, David Geffen School of Medicine at UCLA NICHD CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 5112, David Geffen School of Medicine at UCLA NICHD CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.